"In a clinical trial conducted for HSRx Group httphsrxgroup.com an Arizonabased biopharmaceutical company the OTC acne treatment product HSRx  significantly outperformed a marketleading product in reducing acne count redness and severity. The singlesite randomized doubleblind placebo controlled comparative clinical study involved  subjects and calibrated results at       and  days. The trial was conducted by Moore Clinical Research Inc. an independent FDAcompliant contract research organization with considerable experience in acne product testing. For consumers desiring immediate results HSRx  is the clear choice said Thomas Sullivan Jr. Chief Executive Officer of HSRx Group. After  hours treatment the percentage of subjects with reduced acne count was  greater for those using HSRx  than for subjects using the competing product. At  hours the percentage reduction in total acne count with HSRx  was  times greater than it was for subjects using the competing product.  Acne sufferers number one priority is getting rid of inflammatory lesions  pimples  fast Sullivan said. We demonstrated that with HSRx . After  hours the percentage of subjects with unsightly acneassociated redness was reduced nearly three times as much with HSRx  as with the competing product. At seven days the percentage of subjects exhibiting reduced severity was six times greater for those using HSRx  compared to those using the competing product. The HSRx product demonstrated superior treatment performance throughout the entire clinical study. That makes for a powerful marketing advantage Sullivan said. Acne treatment represents a vast global market estimated at  billion annually with significant expansion expected among surging middle class populations in China and India. Acne is a universal plague said Frank Parise HSRx Group Chief Financial Officer citing a recent NASA warning http that even the International Space Station harbors germs that can cause the disease. Acne is among the  most prevalent human infectious diseases and recent studies show it has a significant longterm psychological impact on many of the  of teenagers and young adults who suffer from it he added. Our acne treatment product has enormous commercial potential evidenced by the significant licensee interest it has attracted. As with each of our next generation OTC drug products we intend to license HSRx  to a leading marketing entity that has the resources and expertise to maximize sales here and abroad Parise said. HSRx Group has developed a portfolio of next generation OTC drug products for many categories of common health conditions. Each product is subjected to independently conducted clinical trials against a current marketleading product to demonstrate its ability to deliver superior treatment outcomes with reduced side effects. All HSRx OTC drug products utilize natural ingredients in their formulations. HSRx outlicenses or jointventures its products with select marketing brands. About HSRx Group HSRx Group is a biopharmaceutical company developing next generation combination OTC and breakthrough drugs for the prevention and treatment of a broad group of chronic and infectious disease conditions. The HSRx technology integrates diseasefighting food nutrients with leading generic drugs to create multimechanism pharmaceutical products with long patent lives. Information is available at HSRxGroup.com httphsrxgroup.com.  SOURCE HSRx Group Related Links http"